View in EDS

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.
Authors: Tiong IS; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Dillon R; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.; Guy's Hospital, London, United Kingdom., Ivey A; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Kuzich JA; Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, VIC, Australia., Thiagarajah N; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Sharplin KM; Royal Adelaide Hospital, Adelaide, SA, Australia., Kok CH; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Tedjaseputra A; Monash Health, Melbourne, VIC, Australia., Rowland JP; Princess Alexandra Hospital, Woolloongabba, QLD, Australia., Grove CS; Department of Haematology, Sir Charles Gairdner Hospital and PathWest, Perth, WA, Australia., Abro E; Princess Alexandra Hospital, Woolloongabba, QLD, Australia., Shortt J; Monash Health, Melbourne, VIC, Australia.; School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Hiwase DK; Royal Adelaide Hospital, Adelaide, SA, Australia., Bajel A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Potter NE; Department of Medical and Molecular Genetics, King's College, London, United Kingdom., Smith ML; Department of Haematology, St. Bartholomew's Hospital, London, United Kingdom., Hemmaway CJ; Department of Haematology, Auckland City Hospital, Auckland, New Zealand; and., Thomas A; Centre for Trials Research and., Gilkes AF; Department of Haematology, Cardiff University, Cardiff, United Kingdom., Russell NH; Guy's Hospital, London, United Kingdom., Wei AH; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
Source: Blood advances [Blood Adv] 2021 Dec 14; Vol. 5 (23), pp. 5107-5111.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34555849
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tiong+IS%22">Tiong IS</searchLink>; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Dillon+R%22">Dillon R</searchLink>; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.; Guy's Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ivey+A%22">Ivey A</searchLink>; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kuzich+JA%22">Kuzich JA</searchLink>; Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Thiagarajah+N%22">Thiagarajah N</searchLink>; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Sharplin+KM%22">Sharplin KM</searchLink>; Royal Adelaide Hospital, Adelaide, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Kok+CH%22">Kok CH</searchLink>; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Tedjaseputra+A%22">Tedjaseputra A</searchLink>; Monash Health, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Rowland+JP%22">Rowland JP</searchLink>; Princess Alexandra Hospital, Woolloongabba, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Grove+CS%22">Grove CS</searchLink>; Department of Haematology, Sir Charles Gairdner Hospital and PathWest, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Abro+E%22">Abro E</searchLink>; Princess Alexandra Hospital, Woolloongabba, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Shortt+J%22">Shortt J</searchLink>; Monash Health, Melbourne, VIC, Australia.; School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Hiwase+DK%22">Hiwase DK</searchLink>; Royal Adelaide Hospital, Adelaide, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Bajel+A%22">Bajel A</searchLink>; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Potter+NE%22">Potter NE</searchLink>; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Smith+ML%22">Smith ML</searchLink>; Department of Haematology, St. Bartholomew's Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hemmaway+CJ%22">Hemmaway CJ</searchLink>; Department of Haematology, Auckland City Hospital, Auckland, New Zealand; and.<br /><searchLink fieldCode="AU" term="%22Thomas+A%22">Thomas A</searchLink>; Centre for Trials Research and.<br /><searchLink fieldCode="AU" term="%22Gilkes+AF%22">Gilkes AF</searchLink>; Department of Haematology, Cardiff University, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Russell+NH%22">Russell NH</searchLink>; Guy's Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wei+AH%22">Wei AH</searchLink>; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2021 Dec 14; Vol. 5 (23), pp. 5107-5111.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34555849
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2021005455
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5107
    Titles:
      – TitleFull: Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tiong IS
      – PersonEntity:
          Name:
            NameFull: Dillon R
      – PersonEntity:
          Name:
            NameFull: Ivey A
      – PersonEntity:
          Name:
            NameFull: Kuzich JA
      – PersonEntity:
          Name:
            NameFull: Thiagarajah N
      – PersonEntity:
          Name:
            NameFull: Sharplin KM
      – PersonEntity:
          Name:
            NameFull: Kok CH
      – PersonEntity:
          Name:
            NameFull: Tedjaseputra A
      – PersonEntity:
          Name:
            NameFull: Rowland JP
      – PersonEntity:
          Name:
            NameFull: Grove CS
      – PersonEntity:
          Name:
            NameFull: Abro E
      – PersonEntity:
          Name:
            NameFull: Shortt J
      – PersonEntity:
          Name:
            NameFull: Hiwase DK
      – PersonEntity:
          Name:
            NameFull: Bajel A
      – PersonEntity:
          Name:
            NameFull: Potter NE
      – PersonEntity:
          Name:
            NameFull: Smith ML
      – PersonEntity:
          Name:
            NameFull: Hemmaway CJ
      – PersonEntity:
          Name:
            NameFull: Thomas A
      – PersonEntity:
          Name:
            NameFull: Gilkes AF
      – PersonEntity:
          Name:
            NameFull: Russell NH
      – PersonEntity:
          Name:
            NameFull: Wei AH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 12
              Text: 2021 Dec 14
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 23
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1